Technical Analysis Of Pfizer Inc.

May 2, 2023 at 7:12 AM EDT

Looking at the PFE‘s chart, we can see that it has been in a downtrend as it was lastly traded at around $39.20.

Black and Gray Laptop Computer

Image Source: Pexels

Today’s instrument is Pfizer Inc.’s stock traded on the NYSE exchange under the ticker PFE.

Looking at the PFE‘s chart, we can see that it has been in a downtrend as it was lastly traded at around $39.20.

Today it is announcing its quarterly earnings and if the market’s anticipation is positive, then it should rise towards its resistance level at around $40.30 and if it manages to pass that level then it could approach the next one at around $42. On the other hand, it could test its 52W low at around $38.30 and if it is not able to hold it above that level then it might reach a new 52W low.

(Click on image to enlarge)

AAATrade's Intraday Technical Analysis of Pfizer Inc. - 02/05/2023

More By This Author:

Daily Technical Analysis Of EURUSD - Friday, April 28
Technical Analysis Of Amazon.com - Friday, April 28
Daily Technical Analysis Of USDJPY - Thursday, April 27

Disclaimer:

Trading is risky. Information presented herein, is not to be construed as a solicitation or an offer to buy or sell any Financial Instrument or to participate in any particular trading strategy. Pfizer’s Inc. logo and any associated brand names are Pfizer’s Inc. trademarks. All other trademarks are property of their respective owners.

Foreign exchange (Forex) trading carries a high level of risk and may not be suitable for all investors. The risk grows as the leverage is higher. Investment objectives, risk appetite and the trader’s level of experience should be carefully weighed before entering the Forex market. There is always a possibility of losing some or all of your initial investment / deposit, so you should not invest money which you cannot afford to lose. The high risk that is involved with currency trading must be known to you. Please ask for advice from an independent financial advisor before entering this market. Any comments made on Forex Crunch or on other sites that have received permission to republish the content originating on Forex Crunch reflect the opinions of the individual authors and do not necessarily represent the opinions of any of Forex Crunch’s authorized authors. Forex Crunch has not verified the accuracy or basis-in-fact of any claim or statement made by any independent author: Omissions and errors may occur. Any news, analysis, opinion, price quote or any other information contained on Forex Crunch and permitted re-published content should be taken as general market commentary. This is by no means investment advice. Forex Crunch will not accept liability for any damage, loss, including without limitation to, any profit or loss, which may either arise directly or indirectly from use of such information.